Xechem International Files Orphan Drug Application With The FDA For The Anti-Sickling Compound Licensed From Virginia Commonwealth University
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--March 14, 2006--Xechem International, Inc. (OTC BB: XKEM) Xechem International announced today that it has submitted its Orphan Drug Application for the five-membered heterocyclic anti-sickling compound known as 5-HMF to the United States Food and Drug Administration (FDA).